FDA Lifts Clinical Hold on Fitusiran
Go back to FDA Lifts Clinical Hold on Fitusiran| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 216.98 -2.22 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.20 | 52 Week High | $109.10 | |||
| Open | $218.00 | 52 Week Low | $31.38 | |||
| Day High | $223.50 | P/E | N/A | |||
| Day Low | $215.61 | EPS | $-1.45 | |||
| Volume | 1,404,787 | |||||
